Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$1.42 - $3.15 $431 - $957
-304 Reduced 0.65%
46,590 $78,000
Q1 2022

May 13, 2022

BUY
$2.65 - $5.08 $1,317 - $2,524
497 Added 1.07%
46,894 $138,000
Q4 2021

Feb 14, 2022

SELL
$4.73 - $7.9 $52,006 - $86,860
-10,995 Reduced 19.16%
46,397 $222,000
Q1 2021

May 17, 2021

BUY
$7.25 - $13.82 $416,092 - $793,157
57,392 New
57,392 $448,000

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.